Inaugural Virtual Symposium: September 24
Register for our free online event: Advances in Drug Discovery and Development.
On September 24, 2014, a world-class group of scientists from biotech, pharma and academia will present the latest research findings and new technologies that are driving the design, discovery and development of new drugs ? from small molecules and monoclonals to RNA therapeutics and gene-editing technologies.
We invite you to be a part of the inaugural C&EN virtual symposium and join a large anticipated audience of thousands of scientists eager to hear the latest science and trends in drug design and development. If you can?t make the live lectures, all presentations will be archived and available on demand for three months.
PROGRAM
Keynote and track speakers have driven R&D inside leading commercial and academic institutions, including Amgen, Biogen-Idec, Novartis, Columbia University, and Harvard/MIT. Hear what they have to say about the current state and future prospects of drug discovery, including:
* Next-gen medicines
* New gene targeting technologies
* Genomic applications
* Business strategies
* Informatics in the R&D environment
REGISTRATION
Register now for free, then log in on September 24 to visit the virtual conference and trade show. It's like being there but without the cost or hassle of travel.
* Participate in panel discussions and Q&A sessions
* "Walk the floor" in our virtual exhibition hall
* Live-chat with peers and vendors
* Download valuable resources
* Re-watch your favorite talks
The C&EN virtual symposium provides a perfect blend of interactivity and convenience. You can build your personal agenda ahead of time; if you are unable to hear a talk live, you can access recordings on demand for up to three months.
Thermo Fisher Scientific is the world leader in serving science. Our mission is to enable our customers to make the world healthier, cleaner, and safer. We serve life science researchers from academic institutions and pharmaceutical industry, providing an unmatched combination of ...
See moreSigma-Aldrich is a leading Life Science and High Technology company whose biochemical, organic chemical products, kits and services are used in scientific research, including genomic and proteomic research, biotechnology, pharmaceutical development, the diagnosis of disease and ...
See moreRegis Technologies, Inc., partners with pharmaceutical and biotechnology companies to help expedite drugs to market. We offer expertise in synthesis, analytical and separation services to advance your active pharmaceutical ingredient (API) from initial process development and ...
See moreChiral Technologies, a wholly owned subsidiary of Daicel Corporation, is the global leader in enantioselective chromatography, serves pharmaceutical and other life science industries and offers the largest portfolio of chiral stationary phases (CSPs) and analytical and ...
See moreSciFinder is a research discovery application that provides integrated access to the world's most comprehensive and authoritative source of references, substances and reactions in chemistry and related sciences.
ACS Chemical Neuroscience publishes high-quality research articles and reviews that showcase chemical, quantitative biological, biophysical and bioengineering approaches to the understanding of the nervous system and to the development of new treatments for neurological ...
See moreACS Publications is pleased to introduce ACS Infectious Diseases, a new journal formed to address the rapidly growing field of research into the molecular basis of infectious disease propagation and therapeutic interventions. This monthly online journal will provide a ...
See moreLabroots is the leading scientific social networking website and producer of educational virtual events and webinars. Contributing to the advancement of science through content sharing capabilities, Labroots is a powerful advocate in amplifying global networks and communities.